The International Grains Council (IGC) has updated its forecasts for global grain and soybean supplies, indicating a tightening in grain stocks while projecting an increase in soybean inventories.

Tuesday, IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia associated with Alzheimer’s. The data demonstrates a clinically ...

Want to stroll around Miami on different bikes? Well, you can do it in Bikelife Miami 2, a free game on the Roblox platform ...

April 16, 2024--(BUSINESS WIRE)--IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) today announced that interim data from its Phase 2 clinical trial demonstrates a ...

The International Grains Council (IGC) cut its forecast for 2024-25 global corn production by 7 MMT to 1.226 billion MT, reflecting a lower outlook for the U.S. crop. However, global corn ...

POTOMAC, Md., April 09, 2024--(BUSINESS WIRE)--IGC Pharma, Inc. ("IGC Pharma," "IGC" or the "Company") (NYSE American: IGC) today announces the addition of Pablo ...

IGC Pharma, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain.

POTOMAC, Md., April 16, 2024 -- ( BUSINESS WIRE )--IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: ...

IGC Pharma Inc (NYSE:IGC) released interim data from its Phase 2 clinical trial of IGC-AD1 for agitation in dementia ...

IGC Pharma, Inc. ("IGC Pharma," "IGC" or the "Company") (NYSE American: IGC) today announces the addition of Pablo Arbelaez, Ph.D., an expert in artificial intelligence (“AI”) and one of the ...